Related Experiment Video
Updated: Apr 12, 2026
12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
13.4K
Characteristics of randomized controlled trials designed for elderly: a systematic review
Karen Broekhuizen1, Axel Pothof2, Anton J M de Craen2
1Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, Netherlands; Institute for Evidence-Based Medicine in Old Age, IEMO, Leiden, Netherlands.
Plos One
|May 16, 2015
Summary
Only 7% of randomized controlled trials (RCTs) are specifically designed for elderly individuals. This highlights a critical gap in research needed to develop effective treatment guidelines for the growing older adult population.
Area of Science:
- Gerontology
- Clinical Trials Methodology
- Evidence-Based Medicine
Background:
- Older adults are a rapidly growing demographic in clinical practice.
- Current medical research, particularly randomized controlled trials (RCTs), may not adequately represent the needs of the elderly population.
- A gap exists in understanding the extent to which RCTs are specifically designed for elderly participants.
Purpose of the Study:
- To determine the proportion of RCTs specifically designed for elderly individuals.
- To compare the characteristics of RCTs designed for the elderly versus those not specifically designed for them.
Main Methods:
- A comprehensive literature search of PubMed was conducted for articles published in 2012.
- Included studies were RCTs involving human subjects, excluding secondary analyses.
- RCTs were classified as specifically designed for the elderly if they used a lower age cutoff of ≥ 55 years or had a mean participant age of ≥ 70 years.
Main Results:
- Out of 1369 analyzed RCTs, only 96 (7%) were specifically designed for the elderly.
- RCTs designed for the elderly had a significantly larger median sample size (125 vs. 80).
- Elderly-focused RCTs were more prevalent in the eye, musculoskeletal, and circulatory system disease categories.
Conclusions:
- A low proportion of existing RCTs are specifically designed for elderly populations.
- There is an urgent need for more research tailored to older adults to inform treatment guidelines.
- Addressing this research gap is crucial as the elderly increasingly represent the majority in medical practice.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
365
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
365
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
333
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
333
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
343
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
343
01:13Randomized Experiments
9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.3K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
351
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
351
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
329
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
329